RE: Test can tell ......ApoE4
Great article Al......interesting to note that when Dr. Cruz talked about the research they are doing in regards to screening the patients for the New Alzheimers Trial for MCI that is starting later this year, that was one of the screens. ApoE4. It's a well known fact that ApoE4 Carriers are more likely to develop Alzheimers in their lifetime. ELAN's current Trial for AAB001 immunotherapy has a complete separate arm for ApoE4 for dosing reasons.....
I'm sure Transition won't be paying $399 a pop though. LOL!!